Choksi Laboratories Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN L85195MP1993PLC007471 Incorporated 29 January 1993 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Listed - BSE: 526546 Public Limited Company pharma
Data last updated
Market Cap
₹132 Cr
CHOKSILA · BSE
Share Price
₹182.50
-3.97% today
Revenue
₹46.01 Cr
FY 2025-26 · +11.0% YoY
EBITDA
₹12.18 Cr
Margin 26.5%
Net Profit
₹1.04 Cr
FY 2025-26 · -31.6% YoY
P/E (TTM)
69.6x
P/B 5.2x
ROE
4.2%
ROCE 9.1%
Debt / Equity
1.29
Interest cover 56.2x

About Choksi Laboratories Limited

Data last updated: 28 September 2026

Choksi Laboratories Limited is a public limited company based in Indore, Madhya Pradesh, India. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 29 January 1993, the company has been in operation for over 33 years.

Registered with ROC Gwalior under CIN L85195MP1993PLC007471. Listed on BSE: 526546.

Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹6.97 Cr. Formerly known as Choksi Analytical Services Limited. It is led by directors including Himika Choksi and Raghmendra Singh.

Last AGM: 16 September 2025. Financial statements filed for year ended 31 March 2025. Office: 1 Near Tulsiyana Industrial Park, Indore, Madhya Pradesh.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹46.01 Cr, a growth of 10.12% compared to the previous year. The net worth stands at ₹25.58 Cr (up 8.34% YoY). Total assets are valued at ₹61.84 Cr (up 13.16% YoY).

The company has a workforce of approximately 318 employees as per the latest available data.

The company is associated with 1 brand - Choksi Laboratories. As per MCA filings, the company has open charges of ₹34.16 Cr and satisfied charges of ₹49.89 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website choksilab.com.

Company Details of Choksi Laboratories Limited
CIN L85195MP1993PLC007471
Registration Number 007471
Incorporation Date 29 January 1993
ROC Gwalior
Listing Status Listed (BSE: 526546)
Company Status Active
Date of Last AGM 16 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Survey No 9/1 Near Tulsiyana Industrial Park Gram Kum, Erdi, Indore, Madhya Pradesh, India – 452010
  • Industry
    Pharma, Pharma Contract R&D
Company report
Choksi Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Choksi Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Choksi Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Choksi Laboratories Limited

Choksi Laboratories Limited operates one associated brand: Choksi Laboratories. These brands represent Choksi Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Laboratory services for pharmaceutical and food analysis are provided. choksilab.com

Business Activity of Choksi Laboratories Limited

Choksi Laboratories Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including architecture, engineering activities, technical testing and analysis activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M4 Architecture, engineering activities, technical testing and analysis activities Locked
Premium access

Business activity turnover details for Choksi Laboratories Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Choksi Laboratories Limited

Choksi Laboratories Limited is audited by Prateek Jain & Co for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Prateek Jain & Co Locked Locked Locked
Premium access

Complete auditor history for Choksi Laboratories Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Choksi Laboratories Limited

Choksi Laboratories Limited is currently managed by 8 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Himika Choksi Whole-Time Director 01 Mar 2017 9 Years 6 Months Current
Raghmendra Singh Director 13 Aug 2022 4 Years 1 Months Current
Vyangesh Choksi Whole-Time Director 01 Aug 2009 17 Years 1 Months Current
Sunil Kumar Choksi Managing Director 01 Sep 2008 18 Years 0 Months Current
Stela Choksi Whole-Time Director 01 Apr 2011 15 Years 5 Months Current
Prachi Mantri Director 03 Feb 2024 2 Years 7 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Choksi Laboratories Limited FY 2025-26 filings available

Choksi Laboratories Limited reported revenue of ₹46.01 Cr (up 10.12% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹46.01 Cr
+10.1% YoY
EBITDA
₹12.18 Cr
+7.8% YoY
Profit After Tax
₹1.04 Cr
-31.6% YoY
Net Worth
₹25.58 Cr
+8.3% YoY
Total Assets
₹61.84 Cr
+13.2% YoY
Total Debt
₹34.17 Cr
+17.2% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue46.0141.7836.7034.4430.0425.6928.16
Revenue growth+11.0%+15.3%+6.8%+17.0%-2.0%-22.3%+4.8%
EBITDA12.1811.3010.279.708.904.120.41
EBITDA margin+26.5%+27.1%+28.0%+28.2%+29.6%+16.0%+1.5%
Profit before tax3.202.151.663.720.36(2.81)(5.71)
Net profit1.041.521.111.640.20(2.62)(0.75)
Net profit margin+2.3%+3.6%+3.0%+4.8%+0.7%-10.2%-2.7%
EPS (₹)2.822.191.594.610.30(3.74)(5.58)
Balance sheet
Total assets61.8454.6554.9055.0556.5857.9654.82
Net worth25.5823.6122.2221.1117.9117.7520.23
Total debt34.1729.1530.8732.4137.2939.1531.64
Cash & bank0.210.610.660.340.410.310.43
Net working capital8.805.647.528.646.184.616.36
Cash flow
Cash from operations7.8611.7811.558.257.885.902.87
Cash from investing(7.07)(7.61)(6.65)(0.71)(2.71)(7.65)(13.76)
Cash from financing(1.20)(4.22)(4.58)(7.61)(5.07)1.6311.09
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue12.0612.8210.8211.1211.2411.4010.389.26
Revenue growth (YoY)+7.3%+12.5%+4.2%+20.1%+4.7%+2.5%+18.1%+16.5%
Other income0.020.060.890.010.000.040.010.01
Total expenses8.789.188.178.198.347.907.846.90
EBITDA3.283.642.652.932.903.502.542.36
EBITDA margin+27.2%+28.4%+24.5%+26.3%+25.8%+30.7%+24.5%+25.5%
Depreciation1.971.891.831.691.681.701.681.61
Interest0.730.710.810.690.600.580.690.66
Profit before tax0.601.100.900.560.621.260.180.10
Tax0.020.070.590.320.240.340.080.02

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 28 Sep 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue12.0612.8210.8211.1211.2411.4010.389.26
Revenue growth (YoY)+7.3%+12.5%+4.2%+20.1%+4.7%+2.5%+18.1%+16.5%
Other income0.020.060.890.010.000.040.010.01
Total expenses8.789.188.178.198.347.907.846.90
EBITDA3.283.642.652.932.903.502.542.36
EBITDA margin+27.2%+28.4%+24.5%+26.3%+25.8%+30.7%+24.5%+25.5%
Depreciation1.971.891.831.691.681.701.681.61
Interest0.730.710.810.690.600.580.690.66
Profit before tax0.601.100.900.560.621.260.180.10
Tax0.020.070.590.320.240.340.080.02
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue46.0141.7836.7034.4430.0425.6928.16
Revenue growth+11.0%+15.3%+6.8%+17.0%-2.0%-22.3%+4.8%
Other income0.970.070.163.040.120.490.33
Total expenses33.8330.4826.4324.7421.1421.5727.75
Employee cost16.6215.2213.0312.0011.0410.7811.70
EBITDA12.1811.3010.279.708.904.120.41
EBITDA margin+26.5%+27.1%+28.0%+28.2%+29.6%+16.0%+1.5%
Depreciation7.096.505.715.505.434.604.56
Interest2.862.723.063.523.232.821.89
Profit before tax3.202.151.663.720.36(2.81)(5.71)
Tax1.230.630.550.510.16(0.20)(1.83)
Net profit1.041.521.111.640.20(2.62)(0.75)
Net profit margin+2.3%+3.6%+3.0%+4.8%+0.7%-10.2%-2.7%
EPS (₹)2.822.191.594.610.30(3.74)(5.58)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital6.976.976.976.976.976.976.97
Reserves & surplus18.6116.6415.2514.1410.9410.7813.26
Shareholders' funds (net worth)25.5823.6122.2221.1117.9117.7520.23
Secured loans27.8328.0729.2730.3533.7735.1430.36
Unsecured loans6.341.081.602.063.524.011.28
Total debt34.1729.1530.8732.4137.2939.1531.64
Total liabilities61.8454.6554.9055.0556.5857.9654.82
Assets
Gross block94.1384.7274.3170.9468.7167.5645.94
Net block51.5547.6243.4444.8346.5650.3233.08
Capital work in progress0.400.002.990.311.670.5013.06
Investments0.000.000.000.000.000.000.00
Inventories0.240.560.360.210.250.110.18
Sundry debtors14.7311.2710.3910.6510.298.166.99
Cash & bank balances0.210.610.660.340.410.310.43
Loans & advances3.703.883.162.753.064.458.95
Total current assets18.8816.3214.5713.9514.0113.0316.55
Total current liabilities10.0810.687.055.317.838.4210.19
Net working capital8.805.647.528.646.184.616.36
Total assets61.8454.6554.9055.0556.5857.9654.82
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.610.660.340.410.310.430.23
Net cash from operating activities7.8611.7811.558.257.885.902.87
Net cash from investing activities(7.07)(7.61)(6.65)(0.71)(2.71)(7.65)(13.76)
Net cash from financing activities(1.20)(4.22)(4.58)(7.61)(5.07)1.6311.09
Net change in cash(0.41)(0.04)0.32(0.07)0.10(0.12)0.20
Closing cash0.210.610.660.340.410.310.43
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+10.1%+13.8%+6.6%+14.7%+16.9%-8.8%-16.6%
EBITDA growth+7.8%+10.0%+5.9%+9.0%+116.0%+904.9%-94.4%
PBT growth+48.8%+29.5%-55.4%+933.3%+9998.0%+50.8%-
Net income growth-31.6%+36.9%-32.3%+720.0%+9998.0%-249.3%-
Revenue CAGR (3Y)+10.1%+11.6%+12.6%+6.9%-3.8%-5.5%-0.7%
EBITDA CAGR (3Y)+7.9%+8.3%+35.6%+187.1%+7.0%-13.4%-55.9%
Profitability & leverage
Net income margin+4.3%+3.6%+3.0%+9.3%+0.7%-10.2%-13.8%
Return on capital employed+9.1%+8.9%+8.6%+8.9%+6.3%+0.0%-1.4%
Return on net worth+4.2%+6.6%+5.1%+8.4%+1.2%-13.7%-3.4%
Debt / equity1.291.311.461.792.141.861.10
Long-term debt / equity0.750.761.021.451.791.590.95
Interest cover56.1956.6767.1183.8193.08-587.50-45.54
Efficiency & per share
Fixed asset turnover0.510.530.510.490.440.450.62
Inventory turnover115.0390.83128.77149.74166.89177.1795.46
Debtors turnover3.543.863.493.293.263.393.57
EPS (₹)2.822.191.594.610.30(3.74)(5.58)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)36.7233.8931.8930.3125.7025.4829.03
Want more history and ratios?
You're viewing the latest exchange-filed financials for Choksi Laboratories Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Choksi Laboratories Limited

As per the shareholding pattern for the quarter ended Mar 2026, promoters hold 31.50%, foreign institutional investors hold 6.00%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 62.50% of Choksi Laboratories Limited.

Promoters: 31.50%FII (Foreign Institutional): 6.00%Retail & Others: 62.50%
Mar 2026
QUARTER
31.50% Promoters
6.00% FII (Foreign Institutional)
62.50% Retail & Others
Promoter holding - history
Now 31.50% · Mar 2026High 31.50% · Jun 2025Low 31.50% · Jun 2025
30%30.8%31.5%32.3%33%Jun 2025Sep 2025Dec 2025Mar 2026Jun 2025: 31.50%Sep 2025: 31.50%Dec 2025: 31.50%Mar 2026: 31.50%31.50%31.50%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025
Promoters31.50%31.50%31.50%31.50%
Public68.50%68.50%68.50%68.50%

Charges & Borrowings of Choksi Laboratories Limited

Open charges
₹34.16 Cr
Satisfied charges
₹49.89 Cr
Breakdown by lending institutions
State Bank of India₹33.15 Cr
Hdfc Bank Limited₹0.81 Cr
Uco Bank₹0.20 Cr
Latest charge details
DateLenderAmountStatus
19 May 2026 Hdfc Bank Limited ₹18.49 Lakh Open
31 May 2025 Hdfc Bank Limited ₹12.5 Lakh Open
23 Jan 2025 State Bank of India ₹6.75 Cr Open
21 May 2024 Hdfc Bank Limited ₹50 Lakh Open
10 Oct 2023 State Bank of India ₹68 Lakh Open

Total charge records: 39 View all charges

Employees and EPFO Compliance at Choksi Laboratories Limited

Choksi Laboratories Limited has a workforce of 318 employees as of Mar 31, 2024.

Employee count
318
Active EPFO establishments
4
Employee growth
1.27%
Premium access

Employee and EPFO history for Choksi Laboratories Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Choksi Laboratories Limited

Premium access

GST registrations and filing compliance for Choksi Laboratories Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Choksi Laboratories Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Choksi Laboratories Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Choksi Laboratories Limited

Premium access

MSME payment history for Choksi Laboratories Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Choksi Laboratories Limited

Premium access

Corporate group structure for Choksi Laboratories Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Choksi Laboratories Limited

Premium access

MCA filings and documents for Choksi Laboratories Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Choksi Laboratories Limited

Directors
13 Jun 2026
Stela Choksi was appointed as a Cfo on 13 Jun 2026 & has been associated with this company since 3 months 18 days.
Charges
09 Jun 2026
A charge with State Bank Of India of Rs. 19.82 Cr registered on 19 Jun 2019 with Charge ID 100271142 was modified on 09 Jun 2026.
Charges
22 May 2026
A charge registered on 29 Sep 2020 via Charge ID 100376418 with State Bank Of India was fully satisfied on 22 May 2026.
Charges
19 May 2026
A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 101303333 was registered on 19 May 2026.
Directors
07 Feb 2026
Ritik Pavecha was appointed as a Director on 07 Feb 2026 & has been associated with this company since 7 months 22 days.
Activity
16 Sep 2025
Choksi Laboratories Limited last Annual general meeting of members was held on 16 Sep 2025 as per latest MCA records.

Recent News on Choksi Laboratories Limited

Frequently Asked Questions about Choksi Laboratories Limited

Choksi Laboratories Limited is an active public limited company in the pharma sector based in Indore, Madhya Pradesh, India. It was incorporated on 29 January 1993 (33+ years old) and is registered under CIN L85195MP1993PLC007471. Listed on BSE: 526546. The company has 318 employees.

Choksi Laboratories Limited reported revenue of ₹46.01 Cr for FY 2025-26 (up 10.12% YoY) based on standalone financials.

The current directors of Choksi Laboratories Limited are:

The primary industry of Choksi Laboratories Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Yes. Choksi Laboratories Limited is listed on BSE with code 526546.

Choksi Laboratories Limited can be reached at the registered office: Survey No 91 Near Tulsiyana Industrial Park Gram Kum, Erdi, Indore, Madhya Pradesh, India – 452010, or through the website choksilab.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available